Download pdf
Advances in nanotechnology for pancreatic cancer therapy: Current status and future prospect
- 1 School of Materials and Chemistry, China University of Metrology, Hangzhou, 310018
* Author to whom correspondence should be addressed.
Abstract
Pancreatic cancer, a highly malignant solid tumor of the digestive tract, is characterized by its challenging early detection, rapid metastatic potential, high degree of aggressiveness, and notably low postoperative survival rate. Current therapeutic options—such as surgery, chemotherapy, or radiotherapy—often prove inadequate due to the disease’s advanced stage at diagnosis, leading to a median survival time of only three to six months post-diagnosis. Given the limitations of conventional treatments, nanotechnology offers promising avenues for addressing key therapeutic challenges in pancreatic cancer. This review explores the progress and potential of various nanotechnology-based interventions, including nano-scaled drug delivery systems, nano-scaled surgical tools like the nanoknife, and nanoperticle-based imaging probe. Each approach provides unique benefits, from enhancing the precision and efficacy of drug delivery to improving diagnostic sensitivity and minimizing collateral damage in treatment. This article summarizes the current landscape of nanotechnology applications in pancreatic cancer therapy and discusses the challenges and future directions for advancing these promising strategies, which may transform the prognosis and quality of life for affected patients.
Keywords
nano, material science, pancreatic cancer, treatment, delivery of drugs
[1]. Liu, Z., Li, Z., Zhang, Y., et al. (2021). Interpretation of the 2020 global cancer statistics report. Electronic Journal of Comprehensive Cancer Therapy, 7(2), 1-13.
[2]. Guo, Y., & Ge, G. (n.d.). EU definition and safety assessment of nanomaterials.
[3]. Huang, Y. (2024). Research progress on the application of nanotechnology in herbicide preparation. Heilongjiang Agricultural Science, 2024(6), 113-118. https://doi.org/10.11942/j.issn1002-2767.2024.06.0113
[4]. Zhao, S., & Zheng, J. (2022). Research progress on etiology and pathogenesis of pancreatic cancer. Chinese Journal of Cancer Prevention and Treatment, 14(3), 253-263.
[5]. 39 Health Network. (2022). Where is pancreatic cancer? Retrieved from https://askar.39.net/a/220831/11660735.html
[6]. Yang, Y. (2015). Hot and difficult points in surgical treatment of pancreatic cancer. Chinese Journal of Digestive Surgery, 14(8), 612-614.
[7]. Mu, W., Chu, Q., Liu, Y., Zhang, N. (2020). A review on nano-based drug delivery system for cancer, chemoimmunotherapy. Micro Letters, 12, 142.
[8]. Zhang, J. (2022). Construction of targeted nano drug delivery systems for enhancing drug delivery and tumor therapy (Doctoral dissertation, Tianjin University).
[9]. Su, D. (2021). The application of nanoknife ablation combined with chemotherapy in the treatment of locally advanced pancreatic cancer (Doctoral dissertation, Zhengzhou University).
[10]. Xu, L. (2022). Preparation of Gd/R848 nano probe and visualization of photothermal immunotherapy for pancreatic cancer cells (Doctoral dissertation, Ningbo University).
[11]. Lu, G. (2019). Experimental study on targeted nanoprobe based on IGF-1R for precise photothermal therapy of pancreatic cancer mediated by optical imaging (Doctoral dissertation, Southern Medical University).
Cite this article
Fu,J. (2024). Advances in nanotechnology for pancreatic cancer therapy: Current status and future prospect. Journal of Food Science, Nutrition and Health,3,23-26.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Journal：Journal of Food Science, Nutrition and Health
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).